Focus on Seasonal Influenza 2025-2026

According to the Centers for Disease Control and Prevention (CDC), an annual influenza vaccine is the “best way to reduce your risk from seasonal flu and its potentially serious complications.” Since 2010 ACIP has recommended routine annual influenza vaccination for everyone 6 months of age or older, unless otherwise contraindicated. As with the 2024-2025 season, all influenza vaccines in the United States will be trivalent formulations. Additionally, in 2025-2026 ACIP has recommended that only single-dose formulations of influenza vaccines without thimerosal be used. Although shortages are not anticipated, availability of specific formulations could be limited.

Download the October 2025 Omnicare HealthLine to read more.